These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 23891744)

  • 1. Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.
    Sun F; Sui C; Zhou Y; Liu X; Shi Y; Wu Y; Li Y
    Int J Pharm; 2013 Sep; 454(1):532-8. PubMed ID: 23891744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of transparent film-forming hydrogels of tolterodine and their effects on stratum corneum.
    Liu X; Fu L; Dai W; Liu W; Zhao J; Wu Y; Teng L; Sun F; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):322-31. PubMed ID: 24882035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.
    Prasanthi D; Lakshmi PK
    Int Braz J Urol; 2013; 39(1):63-75; discussion 76. PubMed ID: 23489517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of hydrogels of 5-hydroxymethyl tolterodine and their studies on pharmacokinetics, pharmacodynamics and transdermal mechanism.
    Liu W; Teng L; Yu K; Sun X; Fan C; Long C; Liu N; Li S; Wu B; Xu Q; Sun F; Li Y
    Eur J Pharm Sci; 2017 Jan; 96():530-541. PubMed ID: 27789373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
    Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies.
    Elshafeey AH; Kamel AO; Fathallah MM
    Pharm Res; 2009 Nov; 26(11):2446-53. PubMed ID: 19697106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.
    Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y
    Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly.
    Ulahannan D; Wagg A
    Clin Interv Aging; 2009; 4():191-6. PubMed ID: 19503781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
    Gillespie JI; Palea S; Guilloteau V; Guerard M; Lluel P; Korstanje C
    BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder.
    Yusup A; Akino H; Miwa Y; Oyama N; Aoki Y; Ito H; Tanase K; Matsuta Y; Nakai M; Yokoyama O
    Eur J Pharmacol; 2007 Dec; 577(1-3):143-9. PubMed ID: 17904547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation.
    Zhao L; Li Y; Fang L; He Z; Liu X; Wang L; Xu Y; Ren C
    Int J Pharm; 2009 Jun; 374(1-2):73-81. PubMed ID: 19446762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
    Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
    Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetic profile of fesoterodine: similarities and differences to tolterodine.
    Simon HU; Malhotra B
    Swiss Med Wkly; 2009 Mar; 139(9-10):146-51. PubMed ID: 19145494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolterodine does not affect memory assessed by passive-avoidance response test in mice.
    Cappon GD; Bush B; Newgreen D; Finch GL; Alper RH
    Eur J Pharmacol; 2008 Jan; 579(1-3):225-8. PubMed ID: 18031724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction.
    Streng T; Andersson KE; Hedlund P; Gratzke C; Baroni E; D'Ambrosio D; Benigni F
    BJU Int; 2012 Jul; 110(2 Pt 2):E125-31. PubMed ID: 22288904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolterodine activates the prefrontal cortex during bladder filling in OAB patients: a real-time NIRS-urodynamics study.
    Sakakibara ; Tateno F; Yano M; Takahashi O; Sugiyama M; Ogata T; Kishi M; Tsuyusaki Y; Yamamoto T; Uchiyama T; Yamanishi T; Shibata C
    Neurourol Urodyn; 2014 Sep; 33(7):1110-5. PubMed ID: 24038213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
    Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
    BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.